Bill Status of SB3851

  1. Home
  2. Legislation
  3. Bill Status

SB3851 - 104th General Assembly

USE/OCC TX-EXEMPT PRESCRIPTION
Last Action
2/24/2026 - Senate: Assigned to Revenue
Senate Sponsors
Sen. Darby A. Hills
Statutes Amended In Order of Appearance
35 ILCS 5/901
35 ILCS 105/3-5
35 ILCS 105/3-10from Ch. 120, par. 439.33-10
35 ILCS 110/3-5
35 ILCS 110/3-10
35 ILCS 115/3-5
35 ILCS 115/3-10
35 ILCS 120/2-5
35 ILCS 120/2-10from Ch. 120, par. 441-10
Synopsis As Introduced
Amends the Use Tax Act, the Service Use Tax Act, the Service Occupation Tax Act, and the Retailers' Occupation Tax Act. Provides that prescription medicines and products classified as Class III medical devices by the United States Food and Drug Administration that are used for cancer treatment pursuant to a prescription are exempt from the tax under the Acts. Amends the Illinois Income Tax Act. Increases the amount deposited into the Local Government Distributive Fund to: (i) 7.47% of the net revenue realized from the tax imposed upon individuals, trusts, estates, and pass-through entities; and (ii) 7.85% of the net revenue realized from the tax imposed upon corporations. Effective July 1, 2026.
Actions
Date Chamber Action
2/06/2026 Senate Filed with Secretary by Sen. John F. Curran
2/06/2026 Senate First Reading
2/06/2026 Senate Referred to Assignments
2/06/2026 Senate Added as Chief Co-Sponsor Sen. Darby A. Hills
2/24/2026 Senate Assigned to Revenue
3/05/2026 Senate Chief Sponsor Changed to Sen. Darby A. Hills
3/13/2026 Senate Rule 2-10 Committee Deadline Established As April 24, 2026